SILO — Silo Pharma, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1514183 ·
Last close
$1.71
Market Cap
$4.00M
52W High
$10.43
52W Low
$1.10
ADV30
41,745
Next earnings
—
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 0 -928,949 -832,829 5,952,023 3,277,095 1,065,733
Mar 2026 18,026 -2,662 -1,594,660 -1,647,117 7,018,132 3,902,514 1,336,296
Dec 2025 18,026 -2,663 -786,524 -881,530 7,605,100 4,748,700 1,299,659
Sep 2025 18,025 -2,662 -1,151,466 -1,110,438 6,384,681 3,917,627 1,375,841

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-3,340,255
Investing CF
$-455,586
Financing CF
$4,860,219
CapEx
$-49,990
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-7.24
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-21,972,335
Inventory
—
Receivables
—
ST Investments
$2,155,561
EBIT TTM
$-4,432,088
Pretax Income TTM
$-4,471,914
Interest Exp TTM
$39,826
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$54,077
EBITDA
$-4,449,849
Free Cash Flow
$-1,642,196
Enterprise Value
$-2,304,862
Total Cash
$5,227,242
Total Debt
$0
Shares Out
2,339,255
Trailing EPS
$-4.26
Book Value
$7.10
ROE
-91.2%
ROA
-44.2%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 72,102 -4,280,662 -4,227,698 7,605,100 1,299,659 6,305,441 -4,661,339
Dec 2024 72,102 -4,705,694 -4,392,880 7,411,840 2,377,575 5,034,265 -3,833,914
Dec 2023 72,102 -3,855,592 -3,700,683 7,746,141 1,569,270 6,176,871 -3,224,498
Dec 2022 72,102 -3,647,656 -3,908,551 11,642,877 1,302,100 10,340,777 -3,497,622

TTM Snapshot

Revenues TTM
$54,077
NetIncome TTM
$-4,471,914
OpCashFlow TTM
—
Assets (Latest)
$5,952,023
Forward EPS
$-0.70

Peers — same industry

TickerNameMarket CapLastDaily %
RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. $4.02M $0.31 —
XTLB XTL BIOPHARMACEUTICALS LTD $3.98M $1.62 —
IMNN Imunon, Inc. $3.97M $0.61 —
KPRX KIORA PHARMACEUTICALS INC $4.11M $0.93 —
TCRT Alaunos Therapeutics, Inc. $4.22M $1.66 —

News headlines (Yahoo Finance, 1h cache)

Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform?
2026-07-15 09:22 · Yahoo
Silo Pharma Shares Slide After Announcing Up to $11.7 Million Private Placement (SILO)
2026-07-10 14:03 · Yahoo
CCC Intelligent Solutions, Circle rise premarket; Silo Pharma, Fermi America fall
2026-07-10 12:57 · Yahoo
Silo Pharma’s QwikAgents Joins AMD AI Developer Program to Advance AI Agent Platform
2026-07-14 14:42 · Yahoo
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
2026-05-04 15:11 · Yahoo
Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform
2026-07-14 12:55 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.